Clotilde Bravetti
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 16
- Chronic Lymphocytic Leukemia Research 14
-
- Lymphoma Diagnosis and Treatment 13
- Co-authors
- Frédéric Davi (9 shared papers)Damien Roos‐Weil (9 shared papers)Élise Chapiro (6 shared papers)Marine Armand (5 shared papers)Florence Nguyen‐Khac (7 shared papers)Marine Baron (5 shared papers)Jonathan Caron (2 shared papers)Dominique Bonnefont‐Rousselot (1 shared paper)
- Journals
- HemaSphere (4 papers)Leukemia (3 papers)American Journal of Hematology (2 papers)Blood (2 papers)British Journal of Haematology (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Clotilde Bravetti
22 papers receiving 292 citations
Peers
Comparison fields: 5 of 40
- Genetics 105
- Pathology and Forensic Medicine 90
- Neurology 73
- Oncology 89
- Hematology 31
Countries citing papers authored by Clotilde Bravetti
This map shows the geographic impact of Clotilde Bravetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clotilde Bravetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clotilde Bravetti more than expected).
Fields of papers citing papers by Clotilde Bravetti
This network shows the impact of papers produced by Clotilde Bravetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clotilde Bravetti. The network helps show where Clotilde Bravetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Clotilde Bravetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 61 | |
| 2 | 2024 | 42 | |
| 3 | 2021 | 34 | |
| 4 | 2016 | 30 | |
| 5 | 2024 | 29 | |
| 6 | 2022 | 19 | |
| 7 | 2023 | 17 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2024 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2023 | 2 |
About Clotilde Bravetti
Clotilde Bravetti is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Neurology and Hematology, having authored 27 papers that have together received 297 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (13 papers), Immunodeficiency and Autoimmune Disorders (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), CAR-T cell therapy research (3 papers), Viral-associated cancers and disorders (3 papers), Acute Myeloid Leukemia Research (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Genetics (105 citations), Pathology and Forensic Medicine (90 citations), Neurology (73 citations), Oncology (89 citations) and Hematology (31 citations). Clotilde Bravetti has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Frédéric Davi, Damien Roos‐Weil, Élise Chapiro, Marine Armand, Florence Nguyen‐Khac, Marine Baron, Jonathan Caron, Dominique Bonnefont‐Rousselot, Denis Monneret and Françoise Imbert‐Bismut. Their work appears in journals such as HemaSphere, Leukemia, American Journal of Hematology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.